Market Place
Sourcing Support
Pelthos Therapeutics Reveals Q3 Fiscal 2025 Financials
13 Nov 2025 //
GLOBENEWSWIRE
Pelthos Pharma Acquires Xepi Cream, Announces $18M Financing
07 Nov 2025 //
GLOBENEWSWIRE
Pelthos Therapeutics to Report Q3 2025 Results on Nov. 13, 2024
05 Nov 2025 //
GLOBENEWSWIRE
Pelthos Rolls Out Campaign Aimed At Moms Who `Don`t Mess Around`
10 Oct 2025 //
FIERCE PHARMA
Pelthos Therapeutics Launches Moms Against Molluscum Movement
09 Oct 2025 //
GLOBENEWSWIRE
Pelthos Therapeutics to Join September Investor Conferences
08 Sep 2025 //
GLOBENEWSWIRE
Pelthos to Attend 2025 Wells Fargo Healthcare Conference
02 Sep 2025 //
GLOBENEWSWIRE
Pelthos Therapeutics Reports Q2 2025 Financial Results, Offers
18 Aug 2025 //
GLOBENEWSWIRE
Ligand Partner Pelthos Therapeutics Launches Zelsuvmi™
10 Jul 2025 //
GLOBENEWSWIRE
Ligand Completes Merger with Channel Therapeutics
02 Jul 2025 //
GLOBENEWSWIRE
Pelthos Completes Merger, Closes $50.1M Private Placement
02 Jul 2025 //
GLOBENEWSWIRE
Channel Therapeutics Announces Reverse Common Stock Split
27 Jun 2025 //
GLOBENEWSWIRE
Ligand`s Pelthos Therapeutics to Merge with Channel Therapeutics
17 Apr 2025 //
GLOBENEWSWIRE
Pelthos Therapeutics Establishes Board of Directors
16 Apr 2024 //
BUSINESSWIRE
Ligand Pharma Announces Launch of Pelthos Thera to Commercialization of ZELSUVMI
03 Apr 2024 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.